LY-1

N/A

Report date: 2025/01/26 15:33:08
NME

Base Information

Drug NameLY-1
Drug Alias NamePDE1 inhibitor (Eli Lilly)LY-1
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodiesterase 1 inhibitors
TargetsPhosphodiesterase 1
Therapy Area/IndicationsHypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesEli Lilly And Company
Inactive CompaniesN/A
Active IndicationsHypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A